We are live on
!
Find out more
NovoCure
NVCR
NVCR
238 hedge funds and large institutions have $1.24B invested in NovoCure in 2025 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 100 increasing their positions, 61 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
191% more call options, than puts
Call options by funds: $16.7M | Put options by funds: $5.74M
64% more repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 61
10% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 40
3.34% more ownership
Funds ownership: 82.04% → 85.38% (+3.3%)
4% more capital invested
Capital invested by funds: $1.19B → $1.24B (+$50.9M)
2% less funds holding
Funds holding: 244 → 238 (-6)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
238
Holders Change
-6
Holders Change %
-2.46%
% of All Funds
2.89%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
44
Increased
100
Reduced
61
Closed
40
Calls
$16.7M
Puts
$5.74M
Net Calls
+$11M
Net Calls Change
-$5M
Top Buyers
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$25.8M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$14.3M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$13.4M |
| 4 |
UBS AM
Chicago,
Illinois
|
-$12.4M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$12.1M |
